Mj. Mangino et al., EFFECTS OF THE 5-LIPOXYGENASE INHIBITOR A-64077 ON INTESTINAL HYPOTHERMIC ORGAN PRESERVATION INJURY, The Journal of pharmacology and experimental therapeutics, 281(2), 1997, pp. 950-956
The effects of tile orally active selective 5-lipoxygenase inhibitor Z
ileuton (A-64077, (N-1(1-benzo{b}thien-2-ylethyl)-N-hydroxyurea) were
studied in a canine model of hypothermic intestinal organ ischemia-rep
erfusion (I/R) injury (transplant preservation injury), Forty-eight ho
urs of hypothermic intestinal ischemia utilizing Collin's flush, follo
wed by 1 hr of reperfusion (transplantation) in A-64077-treated animal
s, resulted in a 3-fold increase in intestinal oxygen uptake and blood
flow relative to the untreated controls. The postreperfusion movement
of fluid from the microcirculation into the intestinal lumen signific
antly increased in the control animals at reperfusion, and A-64077 tre
atment dramatically exacerbated this phenomenon. Mucosal neutrophil in
filtration, or the processes leading to infiltration, significantly in
creased after 48 hr of cold ischemia and 1 hr of normothermic reperfus
ion in the untreated animals. A similar response was observed in A-640
77-treated dogs, but the absolute levels of MPO were 10-fold less rela
tive to untreated animals, including intestinal tissue obtained before
I/R. Hypothermic I/R injury in this model resulted in severe histolog
ic injury. A-64077-treated dogs, however, demonstrated significant imp
rovements in histologic injury. Mucosal synthesis of LTB4 rose signifi
cantly after cold I/R injury and was abrogated by A-64077 treatment. T
he synthesis of PGE(2) significantly increased after cold I/R in both
untreated and A-64077-treated dogs. The increase in PGE(2) production
after hypothermic I/R in the A-64077-treated animals was higher relati
ve to the untreated control animals. In conclusion, this study indicat
es that arachidonic acid metabolism via the 5-lipoxygenase pathway pla
ys a significant role in the pathophysiology of hypothermic intestinal
I/R injury, Furthermore, the 5-lipoxygenase inhibitor A-64077 possess
es favorable pharmacologic and biologic responses in this intestinal i
njury and should be considered in the clinical amelioration of intesti
nal transplantation preservation injury.